TrialSignal
Clinical trial intelligence report
Demonstration of ALIGN: Aligning Medications With What Matters Most
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT06335953-Jul 28, 2026
NCT ID
NCT06335953
Status
COMPLETED
Phase
NA
Sponsor
Johns Hopkins University
Executive brief
Investment-Ready Snapshot
Demonstration of ALIGN: Aligning Medications With What Matters Most is a NA clinical asset sponsored by Johns Hopkins University in Polypharmacy, Alzheimer's Disease and Related Dementias, Mild Cognitive Impairment. SEO and diligence focus: Pharmacist-led deprescribing intervention, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT06335953
Indication
Polypharmacy
Modality
behavioral intervention
Target
Pharmacist-led deprescribing intervention
Intervention
Pharmacist-led deprescribing intervention
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.